Citation

Chen YL, Tu PC, Huang TH, Bai YM, Su TP, Chen MH, Wu YT. Sci. Rep. 2021; 11(1): e17082.

Copyright

(Copyright © 2021, Nature Publishing Group)

DOI

10.1038/s41598-021-96645-5

PMID

34429498

PMCID

PMC8385023

Abstract

The ability to classify patients with bipolar disorder (BD) is restricted by their heterogeneity, which limits the understanding of their neuropathology. Therefore, we aimed to investigate clinically discernible and neurobiologically distinguishable BD subtypes. T1-weighted and resting-state functional magnetic resonance images of 112 patients with BD were obtained, and patients were segregated according to diagnostic subtype (i.e., types I and II) and clinical patterns, including the number of episodes and hospitalizations and history of suicide and psychosis. For each clinical pattern, fewer and more occurrences subgroups and types I and II were classified through nested cross-validation for robust performance, with minimum redundancy and maximum relevance, in feature selection. To assess the proportion of variance in cognitive performance explained by the neurobiological markers, multiple linear regression between verbal memory and the selected features was conducted. Satisfactory performance (mean accuracy, 73.60%) in classifying patients with a high or low number of episodes was attained through functional connectivity, mostly from default-mode and motor networks. Moreover, these neurobiological markers explained 62% of the variance in verbal memory. The number of episodes is a potentially critical aspect of the neuropathology of BD. Neurobiological markers can help identify BD neuroprogression.

Language: en

Keywords

Humans; Adult; Female; Male; Middle Aged; Suicide; Hospitalization; Magnetic Resonance Imaging; Cognition; Neuropsychological Tests; Verbal Behavior; Bipolar Disorder; Memory